Dr. LeWinn's Ceramide Balm 30g

Dr. LeWinn’s Eternal Youth Barrier Protect Ceramide Balm is a lightweight, skin barrier support balm designed to deliver long-lasting hydration while helping to protect and strengthen the skin's natural moisture barrier. Formulated with a powerful blend of ceramides, peptides, hyaluronic acid and squalane, this daily moisturising balm helps replenish essential moisture and improve skin resilience for healthier-looking skin.

The weightless, soothing texture sinks effortlessly into the skin, providing lasting hydration without a heavy or greasy feel. Ceramides help seal in moisture and support the skin barrier, while hyaluronic acid works to restore hydration and improve skin suppleness. Squalane helps prevent moisture loss and supports barrier function, leaving skin feeling soft, smooth and comfortable throughout the day.

Peptides help nourish and protect the skin barrier, promoting stronger, more resilient skin. Suitable for all skin types, including sensitive skin, this dermatologically tested formula helps defend against dryness and dehydration while maintaining optimal skin hydration.

Ideal for daily use, this hydrating ceramide balm helps restore comfort, strengthen the skin barrier and support healthy, youthful-looking skin. Dermatologically tested. Suitable for all skin types including sensitive skin.

• Supports and protects the skin barrier

• Long-lasting hydration and nourishment

• With Ceramides, Peptides, Hyaluronic Acid & Squalane

• Suitable for all skin types, including sensitive skin

• Dermatologically tested

• Lightweight, non-greasy balm texture

Key Ingredients

Ceramides: Seals in moisture and hydration in the skin

Squalane: Restores hydration in the skin barrier and prevents moisture loss

Peptide: Nourishes and protects the skin barrier

Hyaluronic Acid: Restores hydration to the skin's moisture barrier

Tested for noticeable results*:

After 1 week:

95% felt skin was more hydrated

82% felt skin was protected all day

*Results based on self evaluation of 20 participants of a 4 week clinical study. Independent Laboratory study.